Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Microdosing psychedelics

Motivations, subjective effects and harm reduction

Datos Bibliográficos

ID14909121
AutoresToby Lea (0000-0001-5942-0550, UNSW Sydney, autor de correspondencia), Nicole Amada (0000-0003-3017-5664, The Graduate Center, CUNY), Henrik Jungaberle (0000-0001-7634-4211), Henrike Schecke (0000-0002-3599-2877, University of Duisburg-Essen), Michael Klein (0000-0003-0072-3690, Catholic University of Applied Sciences)
Año2020
Volumen75
Páginas102600
Fecha de publicación2020-01-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Drug Policy (JOURNAL)
Identificadores de la revistaISSN: 0955-3959 • E-ISSN: 1873-4758
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2019.11.008
PMID31778967
OpenAlexW2990036135
IdiomaEN
Citas recibidas20
Referencias citadas55

Anxiety · Cognition · Hallucinogen · Harm · Harm reduction · Mental health · Mood · Psilocybin · Psychiatry · Public health · Chemical synthesis and alkaloids · Clinical Psychology · Medicine · Neurotransmitter Receptor Influence on Behavior · Nursing · Psychedelics and Drug Studies · Psychology · Social Psychology

  • Predicting Hallucinogen Use During Adolescence and Early Adulthood in Justice-Involved Youth Using the Dual Systems Model

    Open Access•Thomas W Wojciechowski, Thomas Wojciechowski•Substance Use & Misuse•2026

  • Motives for the use of serotonergic psychedelics

    Open Access•Lukas A Basedow, Sören Kuitunen-Paul•Drug and Alcohol Review•2022

  • Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States

    Open Access•Carla J Berg, Darcey M Mccready et al.•Journal of Psychoactive Drugs•2026

  • State Cannabis and Psychedelic Legislation and Microdosing Interest in the US

    Open Access•Kevin H Yang, Nora Satybaldiyeva et al.•JAMA Health Forum•2024

  • Exploring the first use of psychedelic macrodoses in Latin American adults

    Open Access•Oscar Véliz-García, Marcos Domic-Siede•Journal of Psychedelic Studies•2025

  • Decision-Making around Psychedelics for Depression and Anxiety

    Open Access•David T Kryszajtys, Jacqueline L Bender et al.•International Journal of Mental…•2023

  • Demographic, Mental Health, and Substance Use Correlates of Self-Described Medicinal Use, Recreational Use, and Non-Use of Hallucinogenic Drugs

    Open Access•Sophie G Coelho, Hyoun S Kim et al.•International Journal of Mental…•2024

  • Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics

    D J Kruger, Julie Barron et al.•Journal of Psychoactive Drugs•2023

  • Naturalistic Psychedelic Use

    Nicolas G Glynos, Christopher W Fields et al.•Journal of Psychoactive Drugs•2022

  • The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample

    Open Access•James M Zech, Jérémie Richard et al.•Journal of Psychoactive Drugs•2025

  • Global Trends in Psychedelic Microdosing

    Omer A Syed, Rotem Petranker et al.•Journal of Psychoactive Drugs•2024

  • Psychedelic Microdosing among Young Adults from Southern California

    Alyssa F Harlow, Peter S Hendricks et al.•Journal of Psychoactive Drugs•2024

  • Psychedelic Drug Microdosing Practices

    Open Access•Estelle Miller, Vida Bojovic et al.•Journal of Psychoactive Drugs•2024

  • Cultural Divergence in Psychedelic Use among Medical Students

    Open Access•Ahmed Al-Imam, Marek Motyka et al.•European Journal of Investigation…•2024

  • Sociological investigations of human enhancement drugs

    Open Access•Dimitrios Liokaftos•International Journal of Drug…•2021

  • Participant Experiences of Microdosed Lysergic Acid Diethylamide in a 6-Week Randomised Controlled Trial

    Open Access•Robin J Murphy, Mia Wardlaw et al.•Journal of Humanistic Psychology•2025

  • Peyote as Earth Medicine

    Open Access•H Copes, Jared Ragland•The British Journal of Criminology•2024

  • Prevalence of Legal, Prescription, and Illegal Drugs Aiming at Cognitive Enhancement across Sociodemographic Groups in Germany

    Open Access•Simone Sattler, Floris Van Veen et al.•Deviant Behavior•2025

  • Microdosing with classical psychedelics

    Open Access•Alice Wong, Aviad Raz et al.•Transcultural Psychiatric…•2022

  • Exploring the relationship between microdosing, personality and emotional insight

    Open Access•H M Dressler, Stephen J Bright et al.•Journal of Psychedelic Studies•2021

  • Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014

    Open Access•Harry Man Xiong Lai, Michelle Cleary et al.•Drug and Alcohol Dependence•2015

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Journal of Psychopharmacology•2016

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Psychopharmacology•2018

  • Deconstructing the Placebo Effect and Finding the Meaning Response

    Open Access•D E Moerman, Wayne B Jonas•Annals of Internal Medicine•2002

  • Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys

    Open Access•Philip S Wang, Sergio Aguilar-Gaxiola et al.•The Lancet•2007

  • Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder

    Open Access•Andrea Cipriani, Toshi A Furukawa et al.•The Lancet•2018

  • Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression

    Open Access•Fernanda Palhano-Fontes, Dayanna Barreto et al.•Psychological Medicine•2019

  • The Severity of Dependence Scale (SDS)

    Open Access•Michael Gossop, Shane Darke et al.•Addiction•1995

  • Barriers to mental health treatment

    Open Access•Laura Helena Andrade, Jordi Alonso et al.•Psychological Medicine•2014

  • Drug harms in the UK

    Open Access•David J Nutt, Leslie A King et al.•The Lancet•2010

  • Long-term follow-up of psilocybin-facilitated smoking cessation

    Matthew W Johnson, Albert Garcia-Romeu et al.•The American Journal of Drug and…•2017

  • Psychedelics

    Open Access•David E Nichols•Pharmacological Reviews•2016

  • Global burden of disease attributable to mental and substance use disorders

    Open Access•Harvey A Whiteford, Harvey Whiteford et al.•The Lancet•2013

  • Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

    Open Access•Peter Gasser, Dominique Holstein et al.•The Journal of Nervous and Mental…•2014

  • Psilocybin-assisted treatment for alcohol dependence

    Open Access•Michael P Bogenschutz, Alyssa A Forcehimes et al.•Journal of Psychopharmacology•2015

  • An Empirical Evaluation of Alternative Methods of Estimation for Confirmatory Factor Analysis With Ordinal Data.

    David B Flora, Patrick J Curran•Psychological Methods•2004

  • Narrative identity, rationality, and microdosing classic psychedelics

    Open Access•Megan Webb, H Copes et al.•International Journal of Drug…•2019

  • Psychedelic pleasures

    Open Access•Frederik Bøhling•International Journal of Drug…•2017

  • Results of an international drug testing service for cryptomarket users

    Open Access•Fernando Caudevilla, Mireia Ventura et al.•International Journal of Drug…•2016

  • Psychedelic Microdosing

    Toby Lea, Nicole Amada et al.•Journal of Psychoactive Drugs•2019

  • Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration

    James Fadiman, Sophia Korb•Journal of Psychoactive Drugs•2019

  • Voice of the Psychonauts

    Leda Moro, Levente Móró et al.•Journal of Psychoactive Drugs•2011

  • Values and Beliefs of Psychedelic Drug Users

    Melvin Lerner, Michael Lerner et al.•Journal of Psychoactive Drugs•2006

  • Harm Reduction From Below

    Open Access•Inge Van Schipstal, Swasti Mishra et al.•Contemporary Drug Problems•2016

  • Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression

    Open Access•Rosalind Watts, Camilla Day et al.•Journal of Humanistic Psychology•2017

  • Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics

    Open Access•Natasha L Mason, Kim P C Kuypers•Journal of Psychedelic Studies•2018

Obras citantes distintas20
Citas por año4
Intervalo de citas2021 - 2026 (6)
Velocidad de citacióncurrent
Altamente citadoNo
Tipos de citaNeutras: 20
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae